keyword
https://read.qxmd.com/read/38401941/glucose-lightened-upconversion-nanoprobes-for-accurate-cellular-discrimination-based-on-warburg-effect
#21
JOURNAL ARTICLE
Zihe Wang, Cheng Liao, Qi Lu, Yaru Sun, Ying Wang, Yi Zhang, Jinming Liu, Xiaohu Su, Qingsong Mei
Accurate cellular-recognition based disease therapy is of significance for precision medicine. However, except of specific antibody-coupling strategy, very few probes have been reported to efficiently discriminate normal cells and lesion cells through cellular microenvironment. Herein, we proposed a glucose selectively-lightened upconversion nanoprobe to recognize cancer cells from a pile of normal cells based on Warburg effect, that indicated a heightened demand for glucose intake for cancer cells. The nanoprobes were constructed by mesoporous silica-coated upconversion nanoparticles (UCNP@mSiO2 ) with the crucial incorporation of a glucose-responsive modality, benzoboric acid (BA)-modified fluorescein molecules (FITC-BA)...
April 1, 2024: Analytica Chimica Acta
https://read.qxmd.com/read/38386947/overcoming-barriers-to-discovery-and-implementation-of-equitable-pharmacogenomic-testing-in-oncology
#22
REVIEW
Sharon P Shriver, Devon Adams, Brittany Avin McKelvey, Jeannine S McCune, Dale Miles, Victoria M Pratt, Kristine Ashcraft, Howard L McLeod, Hannah Williams, Mark E Fleury
Pharmacogenomics (PGx), the study of inherited genomic variation and drug response or safety, is a vital tool in precision medicine. In oncology, testing to identify PGx variants offers patients the opportunity for customized treatments that can minimize adverse effects and maximize the therapeutic benefits of drugs used for cancer treatment and supportive care. Because individuals of shared ancestry share specific genetic variants, PGx factors may contribute to outcome disparities across racial and ethnic categories when genetic ancestry is not taken into account or mischaracterized in PGx research, discovery, and application...
February 22, 2024: Journal of Clinical Oncology
https://read.qxmd.com/read/38374434/the-frequency-of-pathogenic-variation-in-the-all-of-us-cohort-reveals-ancestry-driven-disparities
#23
JOURNAL ARTICLE
Eric Venner, Karynne Patterson, Divya Kalra, Marsha M Wheeler, Yi-Ju Chen, Sara E Kalla, Bo Yuan, Jason H Karnes, Kimberly Walker, Joshua D Smith, Sean McGee, Aparna Radhakrishnan, Andrew Haddad, Philip E Empey, Qiaoyan Wang, Lee Lichtenstein, Diana Toledo, Gail Jarvik, Anjene Musick, Richard A Gibbs
Disparities in data underlying clinical genomic interpretation is an acknowledged problem, but there is a paucity of data demonstrating it. The All of Us Research Program is collecting data including whole-genome sequences, health records, and surveys for at least a million participants with diverse ancestry and access to healthcare, representing one of the largest biomedical research repositories of its kind. Here, we examine pathogenic and likely pathogenic variants that were identified in the All of Us cohort...
February 19, 2024: Communications Biology
https://read.qxmd.com/read/38353123/cyb5r3-t117s-genetic-mutation-is-associated-with-major-adverse-cardiovascular-and-cerebrovascular-events-in-black-adults
#24
JOURNAL ARTICLE
Rahul Chaudhary, Adam C Straub, Felix E Y Aggor, Ifeoluwa Onasanya, Jordan Richardson, Patrick Strollo, Steven E Reis, Oladipupo Olafiranye
No abstract text is available yet for this article.
February 14, 2024: Circulation. Genomic and Precision Medicine
https://read.qxmd.com/read/38339383/cholangiocarcinoma-insights-established-foundations-and-cutting-edge-innovations-from-dr-james-cleary-s-pioneering-research
#25
JOURNAL ARTICLE
Viviana Cortiana, Harshal Chorya, Muskan Joshi, Shreevikaa Kannan, Diksha Mahendru, Harshitha Vallabhaneni, Helena S Coloma, Yan Leyfman, Chandler H Park
This paper provides insights into the conventional understanding of biliary tract malignancies, with a specific focus on cholangiocarcinoma (CCA). We then delve into the groundbreaking ideas presented by Dr. James Cleary. CCA, originating from biliary tree cells, manifests diverse subtypes contingent upon anatomical localization and differentiation status. These variants exhibit discrete genetic aberrations, yielding disparate clinical phenotypes and therapeutic modalities. Intrahepatic, perihilar, and distal CCAs intricately involve distinct segments of the biliary tree, further categorized as well-differentiated, moderately differentiated, or poorly differentiated adenocarcinomas based on their histological differentiation...
February 1, 2024: Cancers
https://read.qxmd.com/read/38302061/disparities-in-covid-19-mortality-amongst-the-immunosuppressed-a-systematic-review-and-meta-analysis-for-enhanced-disease-surveillance
#26
JOURNAL ARTICLE
Meredith Leston, Willam Elson, Jose M Ordóñez-Mena, Debasish Kar, Heather Whitaker, Mark Joy, Nia Roberts, F D Richard Hobbs, Simon de Lusignan
BACKGROUND: Effective disease surveillance, including that for COVID-19, is compromised without a standardised method for categorising the immunosuppressed as a clinical risk group. METHODS: We conducted a systematic review and meta-analysis to evaluate whether excess COVID-associated mortality compared to the immunocompetent could meaningfully subdivide the immunosuppressed. Our study adhered to UK Immunisation against infectious disease (Green Book) criteria for defining and categorising immunosuppression...
January 30, 2024: Journal of Infection
https://read.qxmd.com/read/38294647/omics-based-molecular-classifications-empowering-in-precision-oncology
#27
REVIEW
Zhaokai Zhou, Ting Lin, Shuang Chen, Ge Zhang, Yudi Xu, Haijiao Zou, Aoyang Zhou, Yuyuan Zhang, Siyuan Weng, Xinwei Han, Zaoqu Liu
BACKGROUND: In the past decades, cancer enigmatical heterogeneity at distinct expression levels could interpret disparities in therapeutic response and prognosis. It built hindrances to precision medicine, a tactic to tailor customized treatment informed by the tumors' molecular profile. Single-omics analysis dissected the biological features associated with carcinogenesis to some extent but still failed to revolutionize cancer treatment as expected. Integrated omics analysis incorporated tumor biological networks from diverse layers and deciphered a holistic overview of cancer behaviors, yielding precise molecular classification to facilitate the evolution and refinement of precision medicine...
January 31, 2024: Cellular Oncology (Dordrecht)
https://read.qxmd.com/read/38276239/cytokine-signatures-for-lung-cancer-diagnosis-in-african-american-populations
#28
JOURNAL ARTICLE
Qixin Leng, Pushpa Dhilipkannah, Feng Jiang
Lung cancer is the leading cause of cancer-related deaths among both men and women. African Americans (AAs) experience disproportionately higher incidence and mortality compared to other ethnic groups. Cytokines play multifaceted and crucial roles in the initiation, progression, and spread of cancer. Our aim was to identify cytokine biomarkers for the early detection of lung cancer in AAs. We examined eight key cytokines (Interleukin-1, IL-6, IL-8, IL-10, IL-12p70, monocyte chemotactic protein-1 (MCP-1), interferon-gamma (IFN-γ), and tumor necrosis factor-alpha (TNF-α)) in the plasma of 104 lung cancer patients and 48 cancer-free individuals using the FirePlex Immunoassay...
January 20, 2024: Journal of Personalized Medicine
https://read.qxmd.com/read/38260595/assessing-the-lack-of-diversity-in-genetics-research-across-neurodegenerative-diseases-a-systematic-review-of-the-gwas-catalog-and-literature
#29
Caroline Jonson, Kristin S Levine, Julie Lake, Linnea Hertslet, Lietsel Jones, Dhairya Patel, Jeff Kim, Sara Bandres-Ciga, Nancy Terry, Ignacio F Mata, Cornelis Blauwendraat, Andrew B Singleton, Mike A Nalls, Jennifer S Yokoyama, Hampton L Leonard
IMPORTANCE: The under-representation of participants with non-European ancestry in genome-wide association studies (GWAS) is a critical issue that has significant implications, including hindering the progress of precision medicine initiatives. This issue is particularly significant in the context of neurodegenerative diseases (NDDs), where current therapeutic approaches have shown limited success. Addressing this under-representation is crucial to harnessing the full potential of genomic medicine in underserved communities and improving outcomes for NDD patients...
January 9, 2024: medRxiv
https://read.qxmd.com/read/38199709/timing-surgical-mitral-valve-repair-for-primary-mitral-regurgitation-an-opportunity-for-sex-guided-precision-medicine
#30
EDITORIAL
Anna Sannino, Federico Fortuni
No abstract text is available yet for this article.
January 16, 2024: Journal of the American College of Cardiology
https://read.qxmd.com/read/38160295/machine-learning-strategies-for-improved-phenotype-prediction-in-underrepresented-populations
#31
JOURNAL ARTICLE
David Bonet, May Levin, Daniel Mas Montserrat, Alexander G Ioannidis
Precision medicine models often perform better for populations of European ancestry due to the over-representation of this group in the genomic datasets and large-scale biobanks from which the models are constructed. As a result, prediction models may misrepresent or provide less accurate treatment recommendations for underrepresented populations, contributing to health disparities. This study introduces an adaptable machine learning toolkit that integrates multiple existing methodologies and novel techniques to enhance the prediction accuracy for underrepresented populations in genomic datasets...
2024: Pacific Symposium on Biocomputing
https://read.qxmd.com/read/38160289/session-introduction-overcoming-health-disparities-in-precision-medicine
#32
JOURNAL ARTICLE
Francisco M De La Vega, Kathleen C Barnes, Keolu Fox, Alexander Ioannidis, Eimear Kenny, Rasika A Mathias, Bogdan Pasaniuc
The following sections are included:OverviewDealing with the lack of diversity in current research datasetsDevelopment of fair machine learning algorithmsRace, genetic ancestry, and population structureConclusionAcknowledgments.
2024: Pacific Symposium on Biocomputing
https://read.qxmd.com/read/38138946/patient-adherence-to-written-instructions-following-complete-allergological-evaluation-for-suspected-beta-lactam-allergy-a-tertiary-hospital-study-in-greece
#33
JOURNAL ARTICLE
Michael Makris, Niki Papapostolou, Maria Pasali, Xenofon Aggelidis, Caterina Chliva, Alexander C Katoulis
BACKGROUND: Beta-lactam (BL) antibiotics are among the most prescribed groups of drugs worldwide and have been implicated in a variety of allergic reactions. There is a paucity of literature regarding patient adherence to prescribed instructions following comprehensive allergy assessments. OBJECTIVE: The objective was to follow up the clinical course of BL allergy in patients who underwent thorough allergological investigation for suspected BL allergy at a tertiary hospital and ascertain patients' compliance with the provided written instructions...
December 17, 2023: Journal of Personalized Medicine
https://read.qxmd.com/read/38138899/the-association-of-psychological-variants-with-back-pain-muscle-endurance-and-functional-limitations-in-an-individual-with-chronic-back-pain
#34
JOURNAL ARTICLE
Raee Saeed Alqhtani, Hashim Ahmed, Adel Alshahrani, Abdullah Mohammed Alyami, Abdur Raheem Khan, Ashfaque Khan
Chronic low back pain (CLBP) substantially impacts quality of life through a multifarious interplay of physical and psychological elements. A comprehensive understanding of this relationship is imperative for developing effective treatment strategies. This study recruited 64 participants (35 males and 29 females) experiencing chronic low back pain to explore the associations between psychological factors, muscle endurance, and functional impairments. The study was conducted over six months in an outpatient department and a rehabilitation unit...
November 29, 2023: Journal of Personalized Medicine
https://read.qxmd.com/read/38133461/the-intersection-between-pharmacogenomics-and-health-equity-a-case-example
#35
REVIEW
Courtney Paetznick, Olihe Okoro
Pharmacogenomics (PGx) and the study of precision medicine has substantial power to either uplift health equity efforts or further widen the gap of our already existing health disparities. In either occurrence, the medication experience plays an integral role within this intersection on an individual and population level. Examples of this intertwined web are highlighted through a case discussion. With these perspectives in mind, several recommendations for the research and clinical communities are highlighted to promote equitable healthcare with PGx integrated...
December 5, 2023: Pharmacy (Basel, Switzerland)
https://read.qxmd.com/read/38081923/single-cell-transcriptome-sequencing-reveals-spatial-distribution-of-il34-cancer-associated-fibroblasts-in-hepatocellular-carcinoma-tumor-microenvironment
#36
JOURNAL ARTICLE
Ganggang Wang, Zhijie Zhou, Wenzhi Jin, Xin Zhang, Hao Zhang, Xiaoliang Wang
We utilized scRNA-seq, a well-established technology, to uncover the gene expression characteristics of IL34+ CAFs within HCC. We analyzed the related mechanisms through in vitro and in vivo assays. To begin, we acquired scRNA-seq datasets about HCC, which enabled us to identify distinct cell subpopulations within HCC tissues. We conducted a differential analysis to pinpoint DEGs associated with normal fibroblasts (NFs) and CAFs. Subsequently, we isolated NFs and CAFs, followed by the sorting of IL34+ CAFs...
December 11, 2023: NPJ Precision Oncology
https://read.qxmd.com/read/38070817/trans-balance-reducing-demographic-disparity-for-prediction-models-in-the-presence-of-class-imbalance
#37
JOURNAL ARTICLE
Chuan Hong, Molei Liu, Daniel M Wojdyla, Jimmy Hickey, Michael Pencina, Ricardo Henao
INTRODUCTION: Risk prediction, including early disease detection, prevention, and intervention, is essential to precision medicine. However, systematic bias in risk estimation caused by heterogeneity across different demographic groups can lead to inappropriate or misinformed treatment decisions. In addition, low incidence (class-imbalance) outcomes negatively impact the classification performance of many standard learning algorithms which further exacerbates the racial disparity issues...
December 7, 2023: Journal of Biomedical Informatics
https://read.qxmd.com/read/38062923/complex-in-vitro-model-a-transformative-model-in-drug-development-and-precision-medicine
#38
REVIEW
Luming Wang, Danping Hu, Jinming Xu, Jian Hu, Yifei Wang
In vitro and in vivo models play integral roles in preclinical drug research, evaluation, and precision medicine. In vitro models primarily involve research platforms based on cultured cells, typically in the form of two-dimensional (2D) cell models. However, notable disparities exist between 2D cultured cells and in vivo cells across various aspects, rendering the former inadequate for replicating the physiologically relevant functions of human or animal organs and tissues. Consequently, these models failed to accurately reflect real-life scenarios post-drug administration...
December 7, 2023: Clinical and Translational Science
https://read.qxmd.com/read/38051091/a-systems-biology-approach-to-understand-the-racial-disparities-in-colorectal-cancer
#39
JOURNAL ARTICLE
Annabelle Nwaokorie, Walter Kolch, Dirk Fey
Racial disparities between Black/African Americans (AA) and White patients in colorectal cancer (CRC) is an ever-growing area of concern. Black/AA show the highest incidence and have the highest mortality among major U.S. racial groups. There is no definite cause other than possible sociodemographic, socioeconomic, education, nutrition, delivery of healthcare, screening, and cultural factors. A primary limitation in this field is the lack of and small sample size of Black/AA studies. Thus, this study aimed to investigate whether differences in gene expression contribute to this ongoing unanswered racial disparity issue...
December 5, 2023: Cancer Res Commun
https://read.qxmd.com/read/38046033/why-do-we-keep-ignoring-sex-in-kidney-disease
#40
REVIEW
Magdalena Jankowska, María José Soler, Kate I Stevens, Roser Torra
Throughout the history of nephrology, little attention has been paid to the sex and gender differences in kidney disease. This lack of awareness prevents optimal diagnosis and management of kidney disease. In today's world of precision medicine, it is imperative to appreciate the differential factors regarding gender and kidney disease. This editorial summarizes the up-to-date literature regarding sex and gender differences in kidney disease and considers areas where knowledge is incomplete and where further research is needed...
December 2023: Clinical Kidney Journal
keyword
keyword
104202
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.